NioCorp Developments Ltd. (”NioCorp” or the “Company”) (NASDAQ:NB) today announced the pricing of its previously announced ...

Cue Biopharma (NASDAQ:CUE) announced the pricing details of its underwritten public offering. The offering includes (i) 13,530,780 shares of its common stock, along with warrants to purchase an ...

The healthcare tech firm wants to raise capital to fund its operations and buy more Bitcoin, though a definitive amount was ...

The chairman of the Securities and Exchange Board of India said on Thursday that the market regulator was working to sort out ...

The offering is expected to close on or about April 16, 2025. All the securities are being offered by Cue Biopharma. Shares were down 6.5% in premarket trade on Tuesday.

Oppenheimer & Co. Inc. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.

Opinion: Eversheds Sutherland attorneys Michael Bahar, Mary Jane Wilson-Bilik, and Alexander Fuchs warn companies that ...

SEBI chief Tuhin Kanta Pandey says efforts are underway to resolve issues delaying NSE's IPO, emphasizing public interest ...

AGNCM and AGNCO preferred stocks outperformed the S&P500 with 40.7% & 33.4% returns. Read here for an analysis of these ...

Figma has confidentially filed for an IPO more than a year after a $20 billion acquisition bid by Adobe fell apart due to ...

Opinion: Willkie attorneys say the SEC's expansion of confidential review could level the playing field for companies that want to raise capital or expand through acquisitions.